| Primary |
| Product Used For Unknown Indication |
91.8% |
| Neutropenia |
2.7% |
| Sarcoma |
2.7% |
| Haematopoietic Stem Cell Mobilisation |
1.4% |
| Lymphoma |
1.4% |
|
| Hepatorenal Syndrome |
25.0% |
| Hypertriglyceridaemia |
25.0% |
| Interstitial Lung Disease |
25.0% |
| Toxic Epidermal Necrolysis |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
54.9% |
| Drug Use For Unknown Indication |
8.0% |
| Acute Myeloid Leukaemia |
6.1% |
| Prophylaxis |
5.1% |
| Breast Cancer Metastatic |
3.3% |
| Lymphoma |
3.1% |
| Bone Marrow Conditioning Regimen |
2.5% |
| Breast Cancer Female |
2.1% |
| Metastatic Gastric Cancer |
1.7% |
| Premedication |
1.6% |
| Bone Pain |
1.4% |
| Mantle Cell Lymphoma |
1.4% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.3% |
| Chemotherapy |
1.2% |
| Hypertension |
1.1% |
| Asthma |
1.0% |
| B-cell Lymphoma |
1.0% |
| Breast Cancer |
1.0% |
| Gout |
1.0% |
|
| Toxic Epidermal Necrolysis |
14.5% |
| Hypertriglyceridaemia |
7.2% |
| Neuropathy Peripheral |
7.2% |
| Pyrexia |
7.2% |
| Renal Failure Acute |
6.0% |
| Vascular Purpura |
6.0% |
| Death |
4.8% |
| Dyspnoea |
4.8% |
| Guillain-barre Syndrome |
4.8% |
| Toe Amputation |
4.8% |
| Bone Pain |
3.6% |
| Hyperkalaemia |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Neutropenia |
3.6% |
| Respiratory Distress |
3.6% |
| Urticaria |
3.6% |
| Vomiting |
3.6% |
| Hepatic Failure |
2.4% |
| Hepatocellular Injury |
2.4% |
| Malaise |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
14.8% |
| Prophylaxis |
10.1% |
| Breast Cancer |
9.0% |
| Acute Lymphocytic Leukaemia |
8.4% |
| Neutropenia |
5.0% |
| Infection |
3.5% |
| T-cell Lymphoma |
3.5% |
| B-cell Lymphoma |
3.4% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Febrile Neutropenia |
2.5% |
| Mantle Cell Lymphoma |
2.5% |
| Chemotherapy |
2.3% |
| Chronic Lymphocytic Leukaemia |
2.2% |
| Hyperthermia |
2.0% |
| Stem Cell Transplant |
2.0% |
| Gastric Cancer |
1.8% |
| Nausea |
1.8% |
| Premedication |
1.8% |
| Liver Transplant |
1.7% |
|
| Thrombocytopenia |
15.0% |
| Sepsis |
9.6% |
| Pancytopenia |
9.0% |
| Febrile Neutropenia |
7.2% |
| Neutropenia |
6.0% |
| Rash Maculo-papular |
4.8% |
| Renal Failure |
4.8% |
| Renal Failure Acute |
4.8% |
| Drug Ineffective |
4.2% |
| Trismus |
4.2% |
| Malaise |
3.6% |
| Pyrexia |
3.6% |
| Rash Erythematous |
3.6% |
| Intestinal Haemorrhage |
3.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.0% |
| Pancreatitis Acute |
3.0% |
| Pneumonia |
3.0% |
| Vomiting |
3.0% |
| Anaemia |
2.4% |
| Aplasia |
2.4% |
|
